This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Coca-Cola Stock Rallies 22% YTD: Should Investors Stay Bullish?
by Zacks Equity Research
KO's focus on core brands, innovation efforts, redefined marketing approach and digital expansion position it for long-term growth.
Philip Morris Stock Trading Above 200 & 50-Day SMA: Should You Buy?
by Zacks Equity Research
Philip Morris is poised for success, bolstered by its robust momentum, commitment to innovative smoke-free solutions and ability to drive profitability.
Post Holdings Up 13% in 3 Months: Should You Cash in or Stay Invested?
by Zacks Equity Research
POST has been benefiting from carryover pricing and operational efficiencies while navigating a challenging macroeconomic environment.
Is Kraft Heinz Stock Set for Success Amid a Weak Consumer Market?
by Zacks Equity Research
KHC strengthens profit margins with effective pricing strategies but faces challenges in consumer demand.
What Does Philip Morris's Sale of Vectura Group Mean for its Future?
by Zacks Equity Research
PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare.
Coca-Cola to Debut RTD Cocktail With Bacardi: Will it Aid the Stock?
by Zacks Equity Research
KO intends to debut BACARDI rum and Coca-Cola as a ready-to-drink cocktail with Bacardi Limited. It aims to become a total beverage company.
GIS Q1 Earnings Top, Organic Sales Dip on Unfavorable Pricing
by Zacks Equity Research
General Mills' first-quarter fiscal 2025 results reflect lower earnings and sales due to the adverse net price realization and mix.
Flowers Foods Stock at a 0.96X P/S Multiple: Is Now the Time to Buy?
by Zacks Equity Research
Flowers Foods gains on core priorities, which include developing its team, focusing on brands, prioritizing margins, and exploring mergers and acquisitions.
FEMSA Stock Declines 20.8% YTD: Is a Recovery on the Horizon?
by Zacks Equity Research
FMX stock's performance is affected by macroeconomic challenges and rising competition, but the FEMSA Forward Strategy positions the company for long-term growth.
Diageo Stock Slides 8% YTD: A Buy Opportunity or Time to Exit?
by Zacks Equity Research
DEO faces hurdles from shifting consumer sentiment and high inventory in LAC, while a cautious consumer backdrop impacts its U.S. Spirits segment in North America.
Pilgrim's Pride Growth Playbook: Why is PPC a Solid Consumer Bet?
by Zacks Equity Research
Pilgrim's Pride's focus on consumer preferences, capacity expansion, brand strengthening and cost reduction is likely to drive long-term growth.
Keurig Dr Pepper Hikes Dividend by 7%: What's Ahead for Investors?
by Zacks Equity Research
KDP hikes its quarterly dividend to 92 cents per share from 86 cents.
AB InBev Stock Gains 9% in 3 Months: Should You Buy, Hold or Sell?
by Zacks Equity Research
BUD's focus on brand investments, premiumization, digital transformation, Beyond Beer expansion and revenue-management initiatives bolsters its performance.
Monster Beverage's Investment Potential: Why MNST Could Surprise You
by Zacks Equity Research
MNST suffers from reduced traffic in convenience stores and a retail shift toward mass and dollar channels. Does the stock hold upward prospects?
United Natural's Secret Sauce: Why UNFI Stock is Poised for Growth
by Zacks Equity Research
UNFI is transforming its operations and investing in technology to improve margins but faces ongoing challenges with retail performance.
Molson Coors' Premiumization & Other Efforts Aid: Apt to Hold?
by Zacks Equity Research
TAP looks good on the back of its strategic efforts. The Acceleration Plan and the premiumization of its portfolio bode well.
Kroger Beats Q2 Earnings Estimates, Updates FY24 Identical Sales View
by Zacks Equity Research
Kroger delivers adjusted earnings of 93 cents per share, edging past the Zacks Consensus Estimate by one cent.
Medifast Trades Near 52-Week Low: Buy, Hold or Sell MED Stock?
by Zacks Equity Research
Amid hurdles like competition and a dynamic consumer landscape, Medifast is taking steps to realign its strategy and capitalize on emerging opportunities.
Church & Dwight Stock's Potential: Can CHD Overcome Recent Hurdles?
by Zacks Equity Research
Church & Dwight's strong brand portfolio, pricing strategies and robust online sales aid amid high costs and volatile consumer behavior.
Kimberly-Clark Stock Up 20% YTD: Should You Buy or Hold Tight?
by Zacks Equity Research
KMB's success comes from its volume-and-mix growth strategy, advanced technologies, streamlined operations, and effective cost management.
Campbell Soup's New Vision: What's Next After Investor Day?
by Zacks Equity Research
CPB unveils a new growth strategy during Investor Day, focusing on accelerating growth and setting industry standards.
How Will the Sale of Better Health VMS Business Aid CLX Stock?
by Zacks Equity Research
Clorox completes the divestiture of its Better Health VMS business. The company's IGNITE strategy also bodes well.
Strength in Key Markets and E-commerce Drives Costco's Sales
by Zacks Equity Research
Costco's ability to offer products at lower prices than many of its competitors is a major draw for its customer base.
Why Investing in Ollie's Bargain Stock is a Smart Move Right Now
by Zacks Equity Research
Ollie's Bargain's commitment to offering value-driven merchandise assortments has made it a formidable player in the marketplace.
NUS Stock Hurt by Customer Acquisition Challenges: How to Play Ahead?
by Zacks Equity Research
Nu Skin encounters macroeconomic challenges related to volatile consumer spending and strong currency headwinds.